Get the App
For Doctors
Login/Sign-up
About
Health Feed
Find Doctors
Health Packages
AllQ&AsTips
Malocclusion Health Feed
Asked for female, 47 years old from Bangalore
Share
Bookmark
Report
Health Query
Share
Bookmark
Report
Asked for male, 44 years old from Kollam
Share
Bookmark
Report
Asked for female, 24 years old from Trichy
Share
Bookmark
Report
Asked for female, 28 years old from Patna
Share
Bookmark
Report
Dermatologist•Nagpur
Asked for female, 42 years old from Kanpur
Share
Bookmark
Report
Asked for female, 28 years old from Gurgaon
Share
Bookmark
Report
Asked for female, 53 years old from Jaipur
Share
Bookmark
Report
Hello ,
your mother is suffering from anaplastic astrocytoma grade 3 left frontal tumor post-op f/b post chemoradiation. On f/u she is on t.encorate 500 mg an antiepileptic drug. Recent mri brain shows local recurrence after 2 years gap but I want to know the size, site of recurrence. To discuss about the treatment. I'm unable to see your dicom files.
your mother is suffering from anaplastic astrocytoma grade 3 left frontal tumor post-op f/b post chemoradiation. On f/u she is on t.encorate 500 mg an antiepileptic drug. Recent mri brain shows local recurrence after 2 years gap but I want to know the size, site of recurrence. To discuss about the treatment. I'm unable to see your dicom files.
23 people found this helpful
Asked for male, 6 years old from Dhanbad
Share
Bookmark
Report
I am sorry to hear about your concern but will be happy to assist you.
The overall thalassemia-free survival of low-risk, hla-matched sibling stem cell transplantation patients is 85 to 90 percent, with a 95 percent overall survival. While not as effective, new approaches to class 2 and 3 patients have significantly improved their overall survival.
Let's connect over a call so that we can discuss your concern in details and make a suitable treatment plan for you.
The overall thalassemia-free survival of low-risk, hla-matched sibling stem cell transplantation patients is 85 to 90 percent, with a 95 percent overall survival. While not as effective, new approaches to class 2 and 3 patients have significantly improved their overall survival.
Let's connect over a call so that we can discuss your concern in details and make a suitable treatment plan for you.
8 people found this helpful
Asked for female, 38 years old from Bangalore
Share
Bookmark
Report
Book appointment with top doctors for Malocclusion treatment
View fees, clinic timings and reviews
Ask a free question
Get FREE multiple opinions from Doctors
posted anonymously